share_log

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga ·  Jun 15 00:31

Gainers

  • Cyclerion Therapeutics (NASDAQ:CYCN) shares moved upwards by 37.4% to $2.9 during Friday's regular session. The market value of their outstanding shares is at $7.2 million.
  • CNS Pharma (NASDAQ:CNSP) stock rose 35.86% to $4.92. The market value of their outstanding shares is at $1.9 million.
  • Longeveron (NASDAQ:LGVN) shares moved upwards by 23.23% to $3.31. The market value of their outstanding shares is at $21.0 million.
  • iSpecimen (NASDAQ:ISPC) stock moved upwards by 19.44% to $0.49. The market value of their outstanding shares is at $4.8 million.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) stock rose 17.8% to $3.32. The market value of their outstanding shares is at $1.9 million.
  • Disc Medicine (NASDAQ:IRON) shares increased by 17.59% to $46.05. The company's market cap stands at $1.1 billion.

Losers

  • Nexalin Technology (NASDAQ:NXL) stock fell 36.2% to $0.88 during Friday's regular session. The company's market cap stands at $6.5 million.
  • Kyverna Therapeutics (NASDAQ:KYTX) shares decreased by 34.46% to $9.46. The market value of their outstanding shares is at $408.0 million.
  • Gain Therapeutics (NASDAQ:GANX) shares fell 32.29% to $1.28. The company's market cap stands at $23.1 million.
  • IN8bio (NASDAQ:INAB) shares declined by 30.06% to $1.18. The company's market cap stands at $51.8 million.
  • Nanoviricides (AMEX:NNVC) shares declined by 25.39% to $1.93. The company's market cap stands at $22.7 million.
  • Rezolute (NASDAQ:RZLT) stock declined by 21.9% to $4.03. The market value of their outstanding shares is at $161.7 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment